TABLE 2

Biodistribution of 64Cu-NO2A-TFpep Using MDA-MB-435 Tumor–Bearing SCID Mice

Time
Tissue0.5 h1 h2 h2-h block4 h24 h
Tumor1.10 ± 0.200.90 ± 0.120.84 ± 0.060.38 ± 0.09*0.28 ± 0.040.19 ± 0.02
Blood1.52 ± 0.180.33 ± 0.100.15 ± 0.020.11 ± 0.020.12 ± 0.030.10 ± 0.02
Brain0.05 ± 0.010.02 ± 0.000.01 ± 0.000.02 ± 0.000.02 ± 0.000.04 ± 0.00
Heart0.40 ± 0.050.16 ± 0.060.04 ± 0.010.13 ± 0.020.04 ± 0.020.07 ± 0.02
Lung2.17 ± 0.230.58 ± 0.040.43 ± 0.040.37 ± 0.040.30 ± 0.080.27 ± 0.08
Liver1.87 ± 0.321.52 ± 0.121.31 ± 0.201.30 ± 0.201.28 ± 0.081.26 ± 0.20
Spleen0.62 ± 0.110.27 ± 0.040.32 ± 0.090.29 ± 0.020.27 ± 0.030.30 ± 0.10
Stomach0.47 ± 0.210.23 ± 0.050.30 ± 0.050.29 ± 0.050.29 ± 0.060.19 ± 0.07
Kidneys23.18 ± 4.4115.38 ± 1.7314.15 ± 2.3013.8 ± 1.089.37 ± 0.872.04 ± 0.64
Muscle0.30 ± 0.120.08 ± 0.010.03 ± 0.010.03 ± 0.000.05 ± 0.030.04 ± 0.02
Pancreas0.51 ± 0.130.17 ± 0.070.16 ± 0.070.12 ± 0.030.14 ± 0.080.10 ± 0.05
Bone0.22 ± 0.080.17 ± 0.030.09 ± 0.040.09 ± 0.050.02 ± 0.010.03 ± 0.00
Intestines1.28 ± 0.370.95 ± 0.071.40 ± 0.341.30 ± 0.601.31 ± 0.351.29 ± 0.47
Urine73.7 ± 8.9286.9 ± 2.7090.1 ± 0.6490.9 ± 1.0690.4 ± 0.4794.2 ± 1.15
  • * P = 0.002, significant, compared with 64Cu-NO2A-TFpep uptake in absence and presence of its nonradioactive copper-labeled counterpart at 2 h after injection.

  • Data presented are %ID/g ± SD, except for intestines and urine, which are %ID ± SD (n = 4).